Covid-19 Update: Indian cases up to 7447, death toll reaches 239

As per the Ministry data, of the total number, 6565 are active cases, 239 are dead, one has migrated, while 642 people have been discharged after recovery.

Published On 2020-04-11 04:35 GMT   |   Update On 2020-04-11 06:01 GMT
Advertisement

New Delhi: The total tally of novel coronavirus cases in India reached up to 7447, the Union Health Ministry said on Saturday.

As per the Ministry data, of the total number, 6565 are active cases, 239 are dead, one has migrated, while 642 people have been discharged after recovery.

Maharashtra remained the worst hit with 1574 active cases, 110 deaths and 188 people having been cured. Tamil Nadu is the second worst hit state in India with a total of 943 cases including 8 deaths.

Advertisement

With more than 180 cases in just 24 hours, the national capital reported the third highest number with 903 active cases, 13 deaths and 25 patients having been discharged after being cured.

Delhi government on Friday declared five more areas in the city as containment zones, taking the total number of Covid-19 hotspots sealed in the national capital to 30.

As per a government notification, the new hotspots include Zakir Nagar in southeast Delhi where Lane no 18 to 22 and nearby areas of Abu Bakar Masjid have been declared as containment zones while the rest of Zakir Nagar has been declared as a buffer zone.

The area around the Dindarpur village in Najafgarh has been made a containment zone after three from a family tested positive for coronavirus.

Delhi Deputy Chief Minister Manish Sisodia tweeted on Friday, "Delhi now has 30 containment zones under operation SHIELD."

Union Health Minister Holds meeting with all States

Dr. Harsh Vardhan, Union Minister of Health and Family Welfare, held a video conference to review actions and preparedness for COVID-19 management through Video Conference (VC), with Health Ministers, Chief Secretaries/Health Secretaries of all States and UTs, today, in the presence of Shri Ashwini Kumar Choubey, Minister of State for Health and Family Welfare.

Dr. Harsh Vardhan suggested that there is a need to make dedicated COVID-19 hospitals in each district of the country and notify them as soon as possible so that people are informed about them. He said that detailed guidelines for which category of healthworker/professional need to use which category of PPE, are available at the Ministry's website (www.mohfw.gov.in) and states need to create awareness about their rational use too. A video highlighting the appropriate use of PPE in different areas of hospitals has been uploaded and available at https://www.youtube.com/watch?v=LzB5krucZoQ&feature=youtu.be

Government of India has announced a sanction of Rs 15,000 Cr for 'India COVID-19 Emergency Response and Health System Preparedness Package'. These funds can be used for treatment of COVID-19 patients and strengthen the medical infrastructure of the country with primary focus on COVID-19. This will boost the number of COVID-19 testing facilities and can be used to purchase Personal Protective Equipment (PPE), Isolation beds, ICU beds, Ventilators and other essential medical equipment and training of medical and paramedical manpower.

39 domestic manufacturers have been developed for Personal Protective Equipment (PPE) and Government of India has taken all required action to ensure adequate supply of PPEs for our frontline workers across all States.

Around 20.4 lakh N-95 masks have been supplied to the States and further procurement has already been initiated to address future requirements. Also, an order for 49000 ventilators has been placed and stock is being taken for future requirements.

Ministry of Health and Family Welfare has also issued guidelines on blood transfusions and voluntary blood donation to ensure adequate stocks of blood & blood components, especially for those patients where blood transfusions is a life saving measure. The guidelines are available at https://www.mohfw.gov.in/pdf/NBTCGUIDANCEFORCOVID19.pdf

Additionally, against the projected requirement of Hydroxychloroquine (HCQ) of 1 crore tablets (including Health Workers dealing with COVID-19 patients, ICU cases and high risk contacts) the availability, as of now, is 3.28 crore tablets, which is 3 times more than required for domestic use in the country. In addition to this, about 2-3 crore more have been stocked up.

Online training on Pregnancy and Labour Management has been taken up by AIIMS as part of their Webinars and is also available at:

https://www.youtube.com/watch?v=MJwgi1LCu8o&feature=youtu.be

As of now, capacity of testing is up-scaled through 146 Government labs, 67 Private labs with more than 16000 collection centres. On 9th April 2020, approximately 16002 tests were taken up, of which 320 were found to be positive (approximately 2%). This figure, however, varies on a day-to-day basis depending on the samples collected.

As of now, 6412 confirmed cases and 199 deaths have been reported. 503 persons have been cured/discharged after recovery.

For all authentic & updated information on COVID-19 related technical issues, guidelines & advisories please regularly visit: https://www.mohfw.gov.in/.

Technical queries related to COVID-19 may be emailed at technicalquery.covid19@gov.in and other queries on ncov2019@gov.in .

In case of any queries on COVID-19, please call at Ministry of Health & Family Welfare helpline no. : +91-11-23978046 or 1075 (Toll-free). List of helpline numbers of States/UTs on COVID-19 is also available at https://www.mohfw.gov.in/pdf/coronvavirushelplinenumber.pdf .

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News